Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2022-01-10 00:00:00 ET · period of report 2022-01-06 · accession 0000899243-22-001521 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-10 | 2022-01-06 | AMLX | MILNE GEORGE M JR | Dir | P - Purchase | $19.00 | +26.3K | 221.4K | +13% | +$500.0K |
| D | 2022-01-10 | 2022-01-06 | AMLX | MILNE GEORGE M JR | Dir | A - Grant | $0.00 | +8,400 | 8,400 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-06 | P | A | 26,315 | $19.00 | 221,396 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-06 | A | A | 8,400 | $0.00 | 8,400 | D | $19.00 · — to 2032-01-06 | 8,400 Common Stock | (F1) This option shall vest in full on the date of the Corporation's 2022 Annual Stockholders Meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. |